Author Archives: ijo013

Innovation

Ultrafiolett EysteinInnovation was one of the topics discussed at the spring’s strategy meeting. In collaboration with the The Department of Biomedicine, we follow up on the matter with a joint seminar on Innovation and biotechnology. May 11th, Professor Ulf Landgren from Uppsala University will hold two seminars on “Innovation and biotechnology” and “Molecular tools for high performance analyzes of proteins and nucleic acids”, the latter is held as a BBB-seminar. It also gives the opportunity to speak with Landgren in smaller groups.

Ulf Landgren delivers a number of inventions that are commercialized successfully, including Padlock method for amplification of DNA and “proximity ligation” that provides ultra-sensitive detection of molecules. The latter method led to the creation of the company OLink (www.olink.com).

Mark the day in your calendar already now

Good innovative weekend

Eystein

Public PhD Defence, week 13

Full page photoIda Wergeland  will defend her PhD thesis on Thursday, March 30th, 2017
Trial lecture: Thursday, March 30th, 2017 at 11:00  AM
Topic:  ”M.tuberculosis versus human immunity: who wins the Battle and why?”
Place:  Large auditorium, Main building, Haukeland University Hospital, Jonas Lies vei 65.
Public defense: Thursday, March 30th, 2017 at 1:00 PM
Place:  Auditorium 1, BB – building, Jonas Lies vei 91
Title of dissertation:  ”Immune cells and soluble immune markers in different stages of tubercuosis. Potential biomarkers for diagnosis and treatment efficacy”
1st opponent: PhD Delia Goletti, Lazzaro Spallanzani National Institute for Infectious Diseases, Italy
2nd opponent: Associate professor Susanne Dam, University of Copenhagen, Denmark.

Press release (only in Norwegian)

Public PhD Defence, week 12

ding_yunpeng_24_03Yunpeng Ding will defend his PhD thesis on Friday March 24th 2017
Trial lecture: Friday March 24th 2017 at 10:15 AM
Topic: Genetic polymorphisms and biochemical mechanisms related to One Carbon Metabolism and cardiovascular disease”
Place: Auditorium 1, BB building, Jonas Lies vei 91
Public defense: Friday March 24th 2017 at 12:15 PM
Place: Auditorium 1, BB building, Jonas Lies vei 91
Title of dissertation:“MTHFD1 and relevant biomarkers in cardiovascular disease. Observational studies in patients with suspected stable angina pectoris in Norway”
1st opponent:PhD Kristina Pentieva, Ulster University, United Kingdom
2nd opponent:Professor Nicholas Greene, University College London, United Kingdom

Press release (in Norwegian)

CCBIO symposium 19–20 April 2017

CCBIO cordially invites you to their 5th CCBIO Annual Symposium at Solstrand 19-20 April 2017. The symposium in beautiful surroundings at Solstrand facilitates that students and researchers can make new contacts and catch up on the latest cancer research in their field. Don’t miss out!

The CCBIO symposium is a combination of invited, renowned international and national speakers and two long poster sessions during which younger researchers present their research. International speakers include the chairman of the Nobel Foundation, Carl-Henrik Heldin, and also John Heymach, Angela Nieto, Robert Gale, Jean-Christoph Bourdon, Krister Wennerberg, Diane Bielenberg, Salem Chouaib, Frederic Amant, Janine Terra Erler and Jeanette Woods. In addition you will get to hear from CCBIO researchers and other national cancer researchers, as well as young and upcoming investigators.

Make sure to register before the hotel is fully booked, and within the deadline 19 March. CCBIO looks forward to welcoming you!

You will find program and registration link at www.ccbiosymposium.no

New Art faculty at UiB

bakke0x2c_per_0x2830x29University of Bergen got a new faculty on January 1st 2017 . The offcial name is Faculty of arts, music and design. It consist of the former Bergen National Academy of the Arts and the Greig Academy. The main purpose of the new faculty is education, artistic development, research and dissemination of art, music and design.

It’s just appointed a faculty director of the new faculty. It’s a person we here at K2 know well. Check who it is here.

Why does the the new faculty affect us at K2? For several reasons. Firstly because music and art has the potential to be used as a part of patient care, or to improve patients’ quality of life. Secondly, because art and design can be used to enhance both research applications and articles. Whether it concerns an application or a publication wishes to sell a message, and the phrase ”a picture tells a thousand words” is still valid. Thirdly, by working with people who are good in the audiovisual expression, we can better dissemination which is one of our main tasks, whether it involves the disclosure of our business in general or procurement of an application. Finally, we must be immodest enough to say maybe we can add something to the new faculty.

There is an increasing requirement to provide funds from externally. To do that, we need to think outside the box. One way is to seek cooperation with the people at the new Facutly of Arts from the points mentioned above.

Per

 

BSCC seminar – March 8th 2017

We wish everyone welcome to the next BSCC seminar, Wednesday 8th of March room B302; main building (sentralblokken), 14:30-15:30.

By Oddbjørn Straume, Hanne Dillekås og Siddharth Shanbhag :
“Escape from tumor dormancy in breast cancer. Role of post-operative wound healing”

More information here.

Public PhD Defence, Week 10

Richard DaviesRichard Allan Davies will defend his PhD thesis on Thursday, March 09th, 2017
Trial lecture: Thursday, March 09th, 2017 at 10:15
Topic: “Biologicals and biosimilars in treatment of inflammatory diseases – their use and criteria for switching”
Place: Auditorium 1, BB-bygget, Jonas Lies vei 91
Public defense: Thursday, March 09th, 2017 at 12:15
Place: Auditorium 1, BB-bygget, Jonas Lies vei 91
Title of dissertation: “Flow cytometry based analyses as a tool in biomarker discovery for patient stratification in primary Sjögren’s syndrome
1st opponent: Professor Kjetil Taskén, Universitetet i Oslo
2nd opponent: Ph.d. Marit Inngjerdingen, Oslo Universitetssykehus

Press release (in Norwegian)